Compare TARS & VRRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TARS | VRRM |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | United States | United States |
| Employees | N/A | 1879 |
| Industry | Medicinal Chemicals and Botanical Products | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.7B |
| IPO Year | 2020 | 2016 |
| Metric | TARS | VRRM |
|---|---|---|
| Price | $75.30 | $16.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $80.56 | $26.90 |
| AVG Volume (30 Days) | 616.6K | ★ 1.8M |
| Earning Date | 06-01-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 48.21 | ★ 347.37 |
| EPS | N/A | ★ 0.85 |
| Revenue | ★ $451,360,000.00 | $132,969,000.00 |
| Revenue This Year | $51.34 | $6.63 |
| Revenue Next Year | $29.34 | $7.66 |
| P/E Ratio | ★ N/A | $20.04 |
| Revenue Growth | ★ 146.71 | 14.61 |
| 52 Week Low | $38.51 | $15.58 |
| 52 Week High | $85.25 | $25.83 |
| Indicator | TARS | VRRM |
|---|---|---|
| Relative Strength Index (RSI) | 62.38 | 30.27 |
| Support Level | $65.62 | N/A |
| Resistance Level | $76.81 | $25.18 |
| Average True Range (ATR) | 3.86 | 0.64 |
| MACD | 1.80 | -0.08 |
| Stochastic Oscillator | 75.85 | 29.92 |
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe, and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three reportable segments: Commercial Services, Government Solutions, and Parking Solutions. Maximum revenue is generated from the Commercial Services segment, which offers toll and violation management solutions and title and registration services for commercial fleet customers, including RACs and FMCs in North America. In Europe, it provides tolling and violations processing services.